Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

NASDAQ:LGND   3:59:58 PM EDT
84.95
-0.07 (-0.08%)
Equity Investments, Mergers / Acquisitions

HitGen Signs Agreement To Buy Vernalis (R&D) Limited For $25 Mln

Published: 10/12/2020 10:21 GMT
Ligand Pharmaceuticals Inc (LGND) - Says It Signs Agreement With Ligand Pharmaceuticals, Vernalis Limited to Buy Vernalis (r&d) Limited for $25 Million.